Advertisement Pharmaceutical Business review - Page 100 of 5217 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
July 24, 2024

FDA grants RMAT designation to AffyImmune’s AIC100 for thyroid cancer

The US Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation for AffyImmune’s CAR T-cell therapy, AIC100, to treat recurrent anaplastic thyroid cancer (ATC).

Continue
The interim results from a Phase I study of AIC100 have shown promising outcomes in the treatment of advanced thyroid cancer. Credit: Colin Behrens from Pixabay.
July 23, 2024

Vividion Therapeutics to expand capabilities with new R&D centre in US

The centre will be a hub for innovation, dedicating over half of its space to advanced research laboratories. Credit: md saidul Islam from Pixabay.
July 22, 2024

Apollo Therapeutics and University of Oxford sign drug discovery partnership

The partnership will expedite patient access to trials and hasten the marketing of new medicines originating from Oxford's research. Credit: Tung Lam from Pixabay.

Contracts

December 14, 2022

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Micrograph of psoriasis vulgaris. Credit: Jenny Giang, Marc A. J. Seelen, Martijn B. A. van Doorn, Robert Rissmann,Errol P. Prens and Jeffrey Damman/ commons.wikimedia.org.

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Harbour BioMed, Moderna partner on immunotherapies development

Kite, Refuge sign license deal for gene expression platform for blood cancers

Deals

Deals July 15, 2024

Merck enhances ophthalmology portfolio with EyeBio acquisition

Pharmaceutical Business Review

Biocon signs licensing and supply deal for diabetes drug in Brazil

Q32 Bio concludes merger deal with Homology Medicines

Zuellig Pharma acquires Cialis and Alimta brands from Lilly

Popular

  1. Diamyd Medical secures FDA fast track status for type 1 diabetes treatment
  2. Lynch Regenerative Medicine secures funds to develop skin regeneration solutions
  3. Merck launches GMP-compliant cell culture media line in China
  4. US FDA grants RMAT designation for Kyverna’s KYV-101
  5. Leqembi gains approval for Alzheimer’s treatment in Israel

PRESS RELEASES

Gerresheimer Remains on Track in First Half of 2024
Gerresheimer Remains on Track in First Half of 2024
RWS Joins Meta’s Open Loop Programme to Shape Future of AI Policy
RWS Joins Meta’s Open Loop Programme to Shape Future of AI Policy
RWS’s Linguistic AI Solution Evolve Wins Prestigious 2024 AI Breakthrough Award
RWS’s Linguistic AI Solution Evolve Wins Prestigious 2024 AI Breakthrough Award
Science-Based Targets Initiative Validates RWS’ Commitment to Reducing Carbon Emissions
Science-Based Targets Initiative Validates RWS’ Commitment to Reducing Carbon Emissions
Tosoh Bioscience and the University of Applied Sciences Mittelhessen Announce Partnership in Continuous Purification of Viruses and Viral Vectors
Tosoh Bioscience and the University of Applied Sciences Mittelhessen Announce Partnership in Continuous Purification of Viruses and Viral Vectors

Suppliers

Whitepapers

Saving Through Partnership and Innovation
Saving Through Partnership and Innovation
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme
Wound Care – Selecting the Right Antiseptic for Your Formulation
Wound Care – Selecting the Right Antiseptic for Your Formulation